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DrRakeshM. Suri (Rochester, Minn). I would like to thank the
Association for the privilege of discussing this paper. By way of
disclosure, I am the principal investigator for the FDA IDE trial
of the Sorin PERCEVAL valve, but I have no disclosures related
to this discussion. I would like to thank Dr Bonaros for sending
me a copy of his manuscript in advance.
Dr Bonaros and his colleagues present a study aiming to eval-
uate the impact of paravalvular leakage, PVL, on hemodynamics
and outcome using the relative amplitude index. The authors
used ROC analysis to determine that a cut-off point of 14 was asso-
ciated with increased perioperative respiratory failure, acute renal
injury, mortality, and cardiac and renal complications. Interest-
ingly, however, amplitude index and PVL were both found to be
independent predictors of mortality at one year.
This is an innovative attempt at developing a simplified
hemodynamic parameter to ascertain the degree of peripros-
thetic regurgitation after TAVR. We recall the recently pub-
lished Sinning aortic regurgitation index that Dr Bonaros has
alluded to today, calculated according to the formula he also
described.
That study, too, utilized ROC analysis delineating an index of
less than 25 as important in predicting increased one-year mortal-
ity compared with those with an index of greater than 25. The
Sinning index also provided additional prognostic information
beyond echocardiographically assessed severity of PVL.
Now, both of these mathematical formulae are so-called simple
bedside assessments of PVL and may potentially facilitate deci-
sions regarding the need for further balloon dilation of the pros-
thesis or perhaps TAVR-in-TAVR procedures to ameliorate
periprosthetic leak in the operating room.
However, the numbers are small in both studies, sowe are mind-
ful of the fact that this may limit the statistical robustness of the
proposed relationship between the relative amplitude index
(RAI) and the aforementioned end points.
Three simple questions, Dr Bonaros. The first, you alluded to
this briefly, but can you please describe what you feel is the true
benefit of this new index versus the Sinning index?
Second, the audience would benefit from a description of how
your method might be influenced by alterations in ventricular
load, and particularly, how it might be affected by either a hyper-
trophied ventricle that is poorly compliant and less likely to
tolerate acute aortic insufficiency versus one preconditioned by
the preoperative volume overload associated with significant pre-
existent regurgitation.
And, finally, could Dr Bonaros postulate why the RAI and PVL
in the current analysis were independent predictors of death
considering they are presumably related.
I would like to congratulate Dr Bonaros for an excellent presen-
tation and thank the Association for the privilege of discussing this
important work.
Dr Bonaros. Thank you, Dr Suri, for the excellent remarks. Just
brief answers to your questions.
Number one, the differences between the Sinning index and our
index; I think that both series have a series sample of a little bit
more than 100 patients. I think the Bonow group had 140 patients.
We had 110.gery c March 2014
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surements. This is a decision you reballoon this valve or even to
do a valve-in-valve. But, of course, it is a decision whereby you
can adjust your medical therapy for those patients to reduce the
afterload after the procedure on the ward or even ambulatory.
This is the first thing. And, of course, you don’t need any invasive
measurement with a catheter in the left ventricle or even
echocardiography.
For your second question, I agree with you that there is a very
huge difference if the patients had preexisting regurgitation or
this regurgitation happens acutely. So patients with preexisting
regurgitation, in other words with a pure aortic stenosis, who do
then have periprosthetic regurgitation, they would probably have
an impaired outcome. This is the major hypothesis of this study.
There was a very good article two years ago in American Heart
Journal entitled ‘‘Paravalvular Leakage from Pressure Overload to
Volume Overload.’’ So in this case, we have a volume overload in
the left ventricle, and this ventricle is not able to compensate for
this overload. So there should be some truth in this postulation.
For your third question,wewere also surprised to see that both the
index and the paravalvular regurgitation were independent predic-
tors. I, frankly, do not know the answer to the question. I can only
hypothesize that by using the frame of thevalve in the aortic annulus,
we change the geometry of the annulus, and of coursewe change the
compliance of the aortic root. Soprobably somepart of this so-called
windkessel function of the aortic root is not available anymore.
So probably there should be some correlation there, too, and
the question is what happens? What is the difference betweenThe Journal of Thoracic and Carthe two valve groups we have available for TAVI if a balloon-
expandable valve reacts in a different way than a self-expandable
valve.
Dr Lyle D. Joyce (Rochester, Minn). Are you using this to
change your practice as yet?
Dr Bonaros. To be honest, we have now started to take it into
consideration because we have now finished the evaluation. Again,
the numbers are limited. But we have started to take it into consid-
eration. The example I brought was the last patient we did last
week. We did take the RAI into consideration, yes.
Dr Joyce. Great. Thank you. Very nice presentation.
Dr Joseph J. Rubelowsky (Hattiesburg, Miss). When you
calculated your index, you got a preoperative value, and you sub-
tracted it from your postoperative value. Was there any preopera-
tive regurgitation, and would that influence what your index would
be as your final result?
Let’s say if you had aortic stenosis with a one- or two-plus aortic
regurgitation to begin with, and then you ended up with no aortic
stenosis and maybe one-plus paravalvular leak, would that influ-
ence what your index would be, I mean, when you predicted at
the end?
Dr Bonaros. You are absolutely right. So if you have preexist-
ing regurgitation, the subtrahend of the formula, is going to be
high.
So if the patient had a preexisting regurgitation grade 3 and ends
up a grade 2, he has an improved index. You are absolutely right.
But, fortunately, it was just two patients, so this would not affect
our results. That is a good point.diovascular Surgery c Volume 147, Number 3 1029
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